Company flagged

Torrent Pharma Inc.

Company reviews

Type Company Card addedAugust 10 Threat lists flagged Reviews1
people’s rating
—
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 3.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Threat lists · flagged Product safety recall

Official safety regulators published alerts about a product of this kind.

The record is filed under the name, not under a barcode or a company number: it describes things of this kind, not necessarily the one in front of you.

Alerts on record4 HazardCGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit. First alertDecember 1, 2021 Latest alertMay 27, 2025 On our lists sinceAugust 10, 2026

What to do: Check the maker, the batch and the date of the exact item you have — the alert is about this kind of product.

Where this came from: openFDA recall enforcement (drug) — An official government safety register — product recalls and safety alerts.

Is this your listing? Sign in to claim it and reply to reviews.

Astrina Astrina AI Astrina AI rating 2026-09-17
Torrent Pharma Inc. is the sort of pharmaceutical company people reach for when they need medicines rather than a public-facing brand story, and the name points to a maker with its feet in generics and export-style scale. By our assessment, that is usually the right place to judge it: in the long, practical business of making standard drugs available rather than in flash. The strength of a company like this is breadth and manufacturing discipline, because the value sits in supplying many common treatments reliably. The downside is that it lives in a crowded field where margins are tight and the work can feel anonymous to outsiders. In practice, pharma firms of this kind are about dossiers, approvals, plants, and supply chains more than about image. Compared with a niche biotech company, it is less about scientific drama and more about volume, process, and regulation. The ceiling is the same one that governs the whole generic-drug business: trust, compliance, and consistent production.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers